United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...

FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys ...

Pluristyx, the leading provider of innovative induced pluripotent stem cells (iPSC), announces the issuance of the groundbreaking induced Allogeneic Cell Tolerance (iACT Stealthtm) U.S. Patent No. 12, ...

Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), a $15.77 billion market cap company with an "Excellent" financial health rating according to InvestingPro, executed a ...

On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received ...

Both United Therapeutics and eGenesis have extensively modified pig genes to enhance compatibility and reduce the likelihood of organ rejection. This approach aims to create a viable long-term ...

Currently, there is only one living human recipient of a pig organ: Towana Looney, a 53-year-old from Alabama who received a United Therapeutics kidney on November 25, 2024. She is also the ...

size of the organ and even pig retroviruses that could potentially infect humans. Another biotech company, United Therapeutics, announced this week that it had received the green light from the ...

United Therapeutics will transplant kidneys from animals with ten gene edits, which are meant to increase the likelihood that the human body will accept the organ. More specifically, the company ...

This month also saw United Therapeutics, another developer of engineered transplant organs, announce that it received the agency’s go-ahead to launch a clinical trial of its modified pig kidney.